Diisopropylphosphorofluoridate-induced cholinergic hyperactivity and lipid peroxidation

Toxicology and Applied Pharmacology

Volumn 138, Issue 1, 1996, Pages 48-53

  Yang, Zhen P ^a   Dettbarn, Wolf D ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]METHYL] 3,4 DIHYDRO 2,5,7,8 TETRAMETHYL 2H 1 BENZOPYRAN 6 OL; ATROPINE; BUTHIONINE SULFOXIMINE; DYFLOS; TUBOCURARINE CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC SYSTEM; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; HISTOCHEMISTRY; HYPERACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; MUSCLE NECROSIS; NONHUMAN; RAT;

ANIMALIA;

EID: 0030014636     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0096     Document Type: Article

References (27)

1. Armstrong, R. B. (1990). Initial events in exercise-induced muscular injury. Med. Sci. Sports Exercise 22, 429-435.
2. Bradford, M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
3. Braughler, J. M., Hall, E. D., Jacobsen, E. J., McCall, J. M., and Means, E. D. (1989). The 21-aminosteroids: Potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drug Future 14, 143-152.
4. Chance, B., Sies, H., and Boveris, A. (1979). Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527-605.
5. Clinton, M. E., and Dettbarn, W-D. (1987). Prevention of phospholine-induced myopathy with d-tubocurarine, atropine, diazepam and creatine phosphate. J. Toxicol. Environ. Health 21, 435-444.
6. Clinton, M. E., Misulis, K. E., and Dettbarn, W-D. (1988). Effects of phenytoin, ketamine, and atropine methylnitrate in preventing neuromuscular toxicity of acetylcholinesterase inhibitors soman and diisopropylphosphorofluoridate. J. Toxicol. Environ. Health 24, 439-449.
7. Davison, A., Tibbits, G., Shi, Z. G., and Moon, J. (1988). Active oxygen in neuromuscular disorders. Mol. Cell Biochem. 84, 199-216.
8. Draper, H. H., Squires, E. J., Mahmoodi, H., Wu, J., Agarwal, S., and Hadley, M. (1993). A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radicals Biol. Med. 15, 353-363.
9. 2+] and injury from downhill walking. J. Appl. Physiol. 68, 1241-1251.
10. Ellman, G. L., Courtney, K. D., Andres, V., Jr., and Featherstone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95.
11. Griffith, O. W. (1980). Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106, 207-212.
12. Gupta, R. C., and Dettbarn, W-D. (1987). Alterations of high-energy phosphate compounds in the skeletal muscles of rats intoxicated with diisopropylphosphorofluoridate (DFP) and soman. Fundam. Appl. Toxicol. 8, 400-407.
13. Hall, E. D., Braughler, J. M., Yonkers, P. A., Smith, S. L., Linseman, K. L., Means, E. D., Scherch, H. M., Von Voigtlander, P. F., Lahti, R. A., and Jon Jacobsen, E. (1991). U-78517F: A potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia. J. Pharmacol. Exp. Ther. 258, 688-694.
14. Jackson, M. J., Edwards, R. H. T., and Symons, M. C. R. (1985). Electron spin-resonance studies of intact mammalian skeletal muscle. Biochim. Biophys. Acta 847, 185-190.
15. Jenkins, R. R. (1988). Free radical chemistry: Relationship to exercise. Sports Med. 5, 156-170.
16. Leonard, J. P., and Salpeter, M. M. (1979). Agonist-induced myopathy at the neuromuscular junction is mediated by calcium. Cell Biol. 82, 811-819.
17. Maughan, R. J., Donelly, A. E., Gleeson, M., Whiting, P. H. (1989). Delayed-onset muscle damage and lipid peroxidation in man after a downhill run. Muscle Nerve 12, 332-336.
18. Misulis, K. E., Clinton, M. E., Dettbarn, W-D., and Gupta, R. C. (1987). Differences in central and peripheral neural actions between soman and diisopropyl fluorophosphate, organophosphorus inhibitors of acetylcholinesterase. Toxicol. Appl. Pharmacol. 89, 391-398.
19. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 87, 9383-9387.
20. Packer, L. (1984). Vitamin E, physical exercise and tissue damage in animals. Med. Biol. 62, 105-109.
21. Patterson, G. T., Gupta, R. C., Misulis, K. E., and Dettbarn, W-D. (1988). Prevention of diisopropylphosphorofluoridate (DFP)-induced skeletal muscle fiber lesions in rat. Toxicology 48, 237-244.
22. Reid, M. B., Shoji, T., Moody, M. R., and Entman, M. L. (1992a). Reactive oxygen in skeletal muscle. II. Extracellular release of free radicals. J. Appl. Physiol. 73, 1805-1809.
23. Reid, M. B., Haack, K. E., Franchek, K. M., Valberg, P. A., Kobzik, L., and West, M. S. (1992b). Reactive oxygen in skeletal muscle. I. Intracellular oxidant kinetics and fatigue in vitro. J. Appl. Physiol. 73, 1797-1804.
24. Sjodin, B., Westing, Y. H., and Apple, F. S. (1990). Biochemical mechanisms for oxygen free radical formation during exercise. Sports Med. 10(4), 236-254.
25. Sket, D., W-D. Dettbarn, Clinton, M. E., Misulis, K. E., Sketelj, J., Cucek, D., and Brzin, M. (1991). Prevention of diisopropylphosphorofluoridate-induced myopathy by botulinum toxin type A blockage of quantal release of acetylcholine. Acta Neuropathol. 82, 134-142.
26. Wecker, L., and Dettbarn, W-D. (1977). Effects of denervation on the production of an experimental myopathy. Exp. Neurol. 57, 94-100.
27. 2-isoprostanes in diisopropyl fluorophosphate induced muscle hyperactivity. FASEB J. 9, A694.